Archived Insight | May 26, 2020

University Business Article on Pandemic and Higher Education

In an article from University Business, Segal's Scott Nostaja gives insight on what issues leaders in higher ed may be grappling with as they steer their institutions into a post-pandemic future.

Read the article.

Questions about this story?

Get in touch with our media team for answers.

Key points from this article

The University Business article provides a high-level look at how institutions of higher education have grappled with the COVID-19 crisis, including:

The priorities of higher ed when the crisis first began unfolding
Why decision-makers have found it difficult to pivot to more long-term, strategic planning about the future
What these same leaders should be doing now to help secure their institution's future

Learn more from our insights

Three Businesspeople Meeting In The Boardroom

Explore What’s Ahead for Fiduciary Liability Insurance

See what’s ahead in fiduciary liability insurance: trends, risk mitigation and renewal prep for plan sponsors, ERISA fiduciaries and insurance buyers.

Insurance, Multiemployer Plans, Public Sector, Healthcare Industry, Higher Education, Corporate

Human First. AI Forward. People-First Strategies for AI Success

AI is reshaping business—are you ready? Get clarity & actionable steps in our upcoming webinar.

Technology, Benefits Administration, Communications, Multiemployer Plans, Public Sector, Healthcare Industry, Higher Education, Architecture Engineering & Construction, Consulting Innovation, Corporate, Benefits Technology, ATC, Organizational Effectiveness, Health, Retirement, Artificial Intelligence

Couple Calculating Bills At Home Using Tablet And Calculator

Proposed Rule on Healthcare Price Transparency Disclosures

A proposed rule would change price transparency requirements for health plans and health insurers, including updated machine-readable file standards.

Health, Compliance, Multiemployer Plans, Public Sector, Healthcare Industry, Higher Education, Architecture Engineering & Construction, Pharmaceutical, Corporate

Read Full Insight

Explore all COVID-19 information

We're regularly publishing information on the coronavirus as the situation changes.

Learn More

This page is for informational purposes only and does not constitute legal, tax or investment advice. You are encouraged to discuss the issues raised here with your legal, tax and other advisors before determining how the issues apply to your specific situations.